Overall, our findings indicate that miR‐21 functions as a tumor facilitator in lung adenocarcinoma through targeting HBP1 and may be a promising candidate for miR‐based therapy against lung adenocarcinoma. This evidence concerns the gene HBP1 and neoplasm.